Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,484
Closed -$1.21M 73
2021
Q2
$1.21M Sell
3,484
-1,459
-30% -$442K 0.05% 203
2021
Q1
$1.38M Sell
4,943
-1,144
-19% -$309K 0.05% 216
2020
Q4
$1.49M Sell
6,087
-7,402
-55% -$1.91M 0.05% 235
2020
Q3
$3.82M Sell
13,489
-3,411
-20% -$951K 0.09% 178
2020
Q2
$4.52M Sell
16,900
-3,100
-16% -$932K 0.16% 142
2020
Q1
$6.33M Hold
20,000
0.27% 81
2019
Q4
$5.93M Hold
20,000
0.2% 116
2019
Q3
$4.66M Hold
20,000
0.17% 146
2019
Q2
$4.68M Hold
20,000
0.17% 144
2019
Q1
$4.73M Sell
20,000
-3,000
-13% -$945K 0.18% 143
2018
Q4
$6.92M Sell
23,000
-8,000
-26% -$2.55M 0.29% 92
2018
Q3
$11M Buy
31,000
+5,400
+21% +$1.86M 0.34% 80
2018
Q2
$7.43M Buy
25,600
+1,600
+7% +$450K 0.24% 102
2018
Q1
$6.57M Hold
24,000
0.24% 113
2017
Q4
$7.65M Sell
24,000
-24,000
-50% -$7.7M 0.27% 98
2017
Q3
$15M Buy
48,000
+6,000
+14% +$1.78M 0.53% 45
2017
Q2
$11.4M Buy
42,000
+17,000
+68% +$4.5M 0.42% 59
2017
Q1
$6.84M Sell
25,000
-3,000
-11% -$848K 0.26% 106
2016
Q4
$7.94M Hold
28,000
0.3% 90
2016
Q3
$8.77M Hold
28,000
0.34% 85
2016
Q2
$6.77M Hold
28,000
0.27% 115
2016
Q1
$7.29M Buy
28,000
+8,000
+40% +$2.11M 0.29% 105
2015
Q4
$6.13M Sell
20,000
-5,000
-20% -$1.44M 0.25% 121
2015
Q3
$7.28M Sell
25,000
-5,000
-17% -$1.65M 0.33% 99
2015
Q2
$12.1M Sell
30,000
-6,000
-17% -$2.41M 0.46% 69
2015
Q1
$15.2M Hold
36,000
0.48% 54
2014
Q4
$12.2M Buy
36,000
+10,000
+38% +$3.24M 0.31% 86
2014
Q3
$8.6M Buy
26,000
+16,000
+160% +$5.28M 0.25% 103
2014
Q2
$3.15M Sell
10,000
-5,000
-33% -$1.5M 0.1% 200
2014
Q1
$4.58M Hold
15,000
0.15% 152
2013
Q4
$4.2M Buy
+15,000
New +$3.88M 0.15% 147

Other funds holding BIIB

BP's BIIB Position: Q3 2021 in Review

BP sold out of Biogen (BIIB) in Q3 2021, closing a stake of 3,484 shares — an estimated $1.21M sold.

BP first reported a position in BIIB in Q4 2013 and held it in 31 quarters. The position peaked at $15.2M in Q1 2015. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • BP reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • BP sold 3,484 Biogen shares in Q3 2021, an estimated $1.21M.
  • BP first reported a position in Biogen in Q4 2013 and held it in 31 quarters.
  • BP's Biogen position peaked at $15.2M in Q1 2015.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.